TrialFind
Saved trials
Back to results
Completed
Phase 2
Phase 3
Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill
NCT01073800
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
University of Alberta
Edmonton, Alberta, Canada
View on ClinicalTrials.gov
Official details
Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill — TrialFind